You can check out the annual or quarterly balance sheets of LENZ Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Total equity

Cash, cash equivalents and short-term investments

5.00%220.00M

33.20%258.38M

39.86%292.35M

-6.88%202.17M

6.84%209.52M

-9.05%193.98M

13.44%209.03M

-7.21%217.11M

-20.49%196.11M

-19.24%213.28M

-31.31%184.26M

-19.78%233.99M

-23.47%246.66M

-22.14%264.10M

-28.85%268.23M

-26.12%291.69M

-15.62%322.29M

91.61%339.18M

--376.98M

--394.80M

--381.96M

--177.01M

- Cash and cash equivalents

-35.63%24.21M

7.51%24.77M

24.91%25.18M

-38.12%25.40M

-55.25%37.61M

-88.50%23.04M

-89.06%20.16M

-77.57%41.05M

-34.61%84.03M

187.00%200.36M

286.04%184.26M

224.50%182.99M

70.95%128.51M

-62.28%69.81M

-87.34%47.73M

-85.72%56.39M

-80.32%75.17M

4.55%185.07M

--376.98M

--394.80M

--381.96M

--177.01M

-Short-term investments

13.89%195.79M

36.67%233.61M

41.45%267.17M

0.40%176.77M

53.39%171.91M

1222.81%170.93M

--188.87M

245.23%176.06M

-5.15%112.08M

-93.35%12.92M

-100.00%0.00

-78.33%51.00M

-52.19%118.16M

26.07%194.28M

--220.50M

--235.29M

--247.12M

--154.11M

----

Receivables

--442.00K

--343.00K

--329.00K

----

-Accounts and notes receivable

--442.00K

--343.00K

--329.00K

----

Inventory

--4.12M

--3.50M

--2.94M

--949.00K

----

Prepaid expenses

119.60%8.72M

62.93%6.14M

109.16%5.80M

11.28%3.88M

27.05%3.97M

14.87%3.77M

28.38%2.77M

-27.09%3.48M

8.55%3.12M

-47.17%3.28M

-69.73%2.16M

-29.82%4.78M

-33.87%2.88M

35.79%6.21M

49.92%7.14M

8.46%6.81M

64.97%4.35M

47.45%4.57M

--4.76M

--6.28M

--2.64M

--3.10M

Other current assets

-100.00%0.00

-439.47%-387.00K

-100.00%0.00

732.46%949.00K

0.00%114.00K

-92.88%114.00K

--114.00K

--1.60M

----

--0.00

--149.00K

Total current assets

9.21%233.28M

35.64%268.37M

42.23%301.41M

-6.21%207.00M

7.15%213.60M

-8.68%197.86M

12.71%211.92M

-7.57%220.70M

-20.63%199.35M

-19.84%216.67M

-31.72%188.02M

-20.00%238.78M

-23.11%251.17M

-21.37%270.31M

-27.87%275.37M

-25.61%298.49M

-15.10%326.64M

90.69%343.76M

--381.74M

--401.23M

--384.75M

--180.27M

Non-current assets

Net Fixed Assets

-28.43%1.52M

-14.04%1.72M

-3.32%1.92M

10.50%2.10M

12.53%2.13M

218.18%2.00M

519.63%1.99M

-92.60%1.91M

-94.41%1.89M

-98.31%627.00K

-98.86%321.00K

26.18%25.73M

76.95%33.80M

90.21%37.08M

56.02%28.21M

36.74%20.39M

715.32%19.10M

916.48%19.50M

--18.08M

--14.91M

--2.34M

--1.92M

-Fixed Assets

----

83.28%3.77M

----

540.81%2.06M

----

-98.98%321.00K

15.94%26.57M

76.76%37.08M

96.94%40.95M

65.91%31.42M

48.45%22.91M

685.62%20.98M

876.56%20.79M

--18.94M

--15.44M

--2.67M

--2.13M

-Accumulated depreciation

----

422.06%355.00K

----

--68.00K

----

-100.00%0.00

-66.81%838.00K

74.85%3.27M

198.22%3.86M

275.09%3.21M

380.95%2.52M

472.78%1.87M

513.74%1.29M

--855.00K

--525.00K

--327.00K

--211.00K

Other non-current assets

11.80%1.79M

75.46%2.45M

81.76%2.54M

14.59%1.60M

6557.14%1.40M

1126.32%1.40M

-18.53%1.40M

-32.50%1.40M

-99.19%21.00K

-96.21%114.00K

-32.97%1.72M

0.98%2.07M

7.33%2.60M

38.48%3.00M

21233.33%2.56M

18545.45%2.05M

233.38%2.43M

--2.17M

--12.00K

--11.00K

--728.00K

Total non-current assets

-11.15%3.31M

22.84%4.17M

31.80%4.46M

12.23%3.71M

13.41%3.73M

423.61%3.39M

678.62%3.39M

-87.97%3.30M

-90.83%3.29M

-98.37%648.00K

-99.07%435.00K

-24.50%27.45M

32.17%35.87M

13.89%39.69M

129.80%46.54M

143.60%36.35M

1053.02%27.14M

1217.08%34.85M

--20.25M

--14.92M

--2.35M

--2.65M

Total assets

8.86%236.60M

35.42%272.54M

42.07%305.88M

-5.94%210.70M

7.25%217.33M

-7.39%201.25M

14.25%215.30M

-15.86%224.01M

-29.40%202.64M

-29.90%217.32M

-41.46%188.46M

-20.49%266.23M

-18.87%287.04M

-18.12%310.00M

-19.92%321.90M

-19.54%334.85M

-8.61%353.79M

106.99%378.61M

--401.99M

--416.15M

--387.11M

--182.91M

Liabilities

Current liabilities

-Other payables

--0.00

----

--0.00

----

--0.00

Accrued expenses

32.14%9.33M

228.28%14.44M

196.58%16.55M

166.02%11.50M

100.17%7.06M

-61.15%4.40M

30.97%5.58M

-19.12%4.32M

-46.84%3.53M

22.73%11.32M

-33.30%4.26M

6.99%5.34M

88.36%6.64M

127.27%9.23M

51.85%6.39M

6.23%5.00M

-7.58%3.52M

-15.19%4.06M

--4.21M

--4.70M

--3.81M

--4.79M

Deferred liabilities

--785.00K

----

Other current liabilities

--785.00K

--0.00

----

--0.00

----

--0.00

Total current liabilities

65.53%17.21M

201.16%25.81M

103.60%21.19M

111.62%16.32M

21.15%10.40M

-54.63%8.57M

116.93%10.41M

-38.50%7.71M

-30.05%8.58M

31.71%18.89M

-63.22%4.80M

-7.30%12.54M

1.67%12.27M

12.35%14.34M

7.41%13.04M

19.98%13.52M

53.58%12.07M

99.67%12.77M

--12.14M

--11.27M

--7.86M

--6.39M

Non-current liabilities

Long-term debt and lease liabilities

-78.56%122.00K

-64.78%237.00K

-57.00%350.00K

-51.63%461.00K

-45.91%569.00K

331.41%673.00K

957.14%814.00K

-98.08%953.00K

-97.92%1.05M

-89.01%156.00K

-95.60%77.00K

1926.60%49.67M

1452.05%50.63M

-68.76%1.42M

-69.81%1.75M

-47.67%2.45M

--3.26M

--4.54M

--5.79M

--4.68M

--0.00

-Long-term lease liabilities

-78.56%122.00K

-64.78%237.00K

-57.00%350.00K

-51.63%461.00K

-45.91%569.00K

331.41%673.00K

957.14%814.00K

-98.08%953.00K

-97.92%1.05M

-89.01%156.00K

-95.60%77.00K

1926.60%49.67M

1452.05%50.63M

-68.76%1.42M

-69.81%1.75M

-47.67%2.45M

--3.26M

--4.54M

--5.79M

--4.68M

----

Other non-current liabilities

--0.00

-100.00%0.00

--0.00

--64.00K

--82.74K

-99.39%110.75K

-100.00%0.00

--0.00

--18.01M

--10.82M

3676.56%2.42M

----

--0.00

--64.00K

Total non-current liabilities

-78.56%122.00K

-64.78%237.00K

-57.00%350.00K

-54.67%461.00K

-49.86%569.00K

152.30%673.00K

957.14%814.00K

-97.95%1.02M

-97.76%1.13M

-98.63%266.75K

-99.39%77.00K

920.38%49.67M

1452.05%50.63M

327.81%19.43M

116.91%12.57M

2.53%4.87M

4996.88%3.26M

6996.88%4.54M

--5.79M

--4.75M

--64.00K

Total liabilities

58.06%17.33M

181.79%26.04M

91.95%21.54M

92.24%16.78M

12.86%10.97M

-51.75%9.24M

130.20%11.22M

-85.97%8.73M

-84.55%9.72M

-43.28%19.15M

-80.97%4.87M

238.24%62.21M

310.29%62.90M

95.13%33.77M

42.78%25.61M

14.81%18.39M

93.51%15.33M

168.03%17.31M

--17.94M

--16.02M

--7.92M

--6.46M

Shareholders' equity

Common equity

36.64%520.44M

46.67%515.57M

46.53%511.24M

10.90%384.94M

20.86%380.87M

13.37%351.52M

-36.64%348.90M

-36.69%347.12M

-42.29%315.13M

-42.90%310.06M

2.02%550.64M

2.31%548.25M

2.53%546.07M

2.69%543.03M

2.73%539.74M

2.55%535.85M

9.36%532.61M

8397.41%528.79M

--525.40M

--522.55M

--487.01M

--6.22M

Preferred equity

----

--150.52M

Retained earnings

-72.19%-300.55M

-68.28%-268.63M

-56.63%-227.14M

-44.49%-191.25M

-42.90%-174.54M

-42.67%-159.63M

60.49%-145.01M

61.54%-132.36M

62.02%-122.15M

57.99%-111.89M

-51.42%-367.05M

-58.00%-344.14M

-66.55%-321.65M

-59.31%-266.34M

-71.49%-242.40M

-77.91%-217.80M

-79.10%-193.12M

-85.15%-167.19M

---141.35M

---122.42M

---107.83M

---90.30M

Capital reserves

36.64%520.44M

46.67%515.57M

46.53%511.24M

10.90%384.94M

20.86%380.87M

13.37%351.52M

-36.64%348.90M

-36.69%347.12M

-42.29%315.13M

-42.90%310.06M

2.02%550.63M

2.31%548.25M

2.53%546.07M

2.69%543.03M

2.73%539.74M

2.55%535.85M

9.36%532.61M

8397.40%528.79M

--525.40M

--522.55M

--487.01M

--6.22M

Gains losses not affecting retained earnings

-1755.26%-629.00K

-465.85%-450.00K

23.47%242.00K

-56.60%227.00K

161.29%38.00K

12400.00%123.00K

--196.00K

650.53%523.00K

77.12%-62.00K

99.79%-1.00K

100.00%0.00

94.05%-95.00K

73.77%-271.00K

-51.78%-469.00K

---1.05M

---1.60M

---1.03M

---309.00K

----

Total equity

6.25%219.26M

28.37%246.49M

39.32%284.34M

-9.92%193.93M

6.97%206.37M

-3.11%192.01M

11.17%204.08M

5.52%215.28M

-13.93%192.92M

-28.26%198.17M

-38.04%183.58M

-35.53%204.02M

-33.77%224.15M

-23.55%276.22M

-22.85%296.29M

-20.91%316.45M

-10.74%338.46M

104.75%361.30M

--384.05M

--400.13M

--379.18M

--176.46M

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing LENZ stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does LENZ Therapeutics Inc Have?



In its most recent quarterly, LENZ Therapeutics Inc had 24.21M in cash and cash equivalents.

How Much Are LENZ Therapeutics Inc's Total Liabilities?



LENZ Therapeutics Inc reported 21.54M in total liabilities as of the latest reported quarter, including 21.19M in current liabilities and 350.00K in non-current liabilities.

What Are LENZ Therapeutics Inc's Total Assets?



As of the latest reported quarter, LENZ Therapeutics Inc's total assets were 305.88M, consisting of 301.41M in current assets and 4.46M in non-current assets.

How Much Shareholders' Equity Does LENZ Therapeutics Inc Have?



LENZ Therapeutics Inc reported 284.34M in total shareholders' equity as of the latest reported quarter.